KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Deferred Taxes (2016 - 2025)

Globus Medical's Deferred Taxes history spans 15 years, with the latest figure at $18.1 million for Q4 2025.

  • For Q4 2025, Deferred Taxes rose 154.55% year-over-year to $18.1 million; the TTM value through Dec 2025 reached $18.6 million, up 114.79%, while the annual FY2025 figure was $18.6 million, 114.79% up from the prior year.
  • Deferred Taxes reached $18.1 million in Q4 2025 per GMED's latest filing, down from $41.8 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $41.8 million in Q3 2025 to a low of -$45.1 million in Q1 2024.
  • Average Deferred Taxes over 5 years is -$10.2 million, with a median of -$6.2 million recorded in 2022.
  • Peak YoY movement for Deferred Taxes: crashed 12170.0% in 2021, then surged 252.15% in 2025.
  • A 5-year view of Deferred Taxes shows it stood at -$14.5 million in 2021, then soared by 64.04% to -$5.2 million in 2022, then crashed by 126.51% to -$11.8 million in 2023, then plummeted by 181.2% to -$33.2 million in 2024, then soared by 154.55% to $18.1 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Deferred Taxes are $18.1 million (Q4 2025), $41.8 million (Q3 2025), and -$41.7 million (Q2 2025).